Oramed Pharmaceuticals Inc.
ORMP· Nasdaq
ORMPOramed Pharmaceuticals Inc.
Filed Mar 27, 2025 · 10-K · 86 days after period end · 0001013762-25-003450
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $0.00 | $681.00K | $681.00K |
| Net Income | -$10.19M | $12.90M | -$8.26M | -$17.83M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oramed Pharmaceuticals Inc. · CIK 1176309 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Mar 27, 2025 · 86 d after period end
